SEC Form D · Amendment · filed December 22, 2021
AmbAgon Therapeutics Inc
Location
SAN FRANCISCO, CA
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (33)
Adam Rosenberg · San Francisco, CADirectorJanwillem Naesens · San Francisco, CADirectorRoel Bulthuis · San Francisco, CADirectorBryan Miller · San Francisco, CAExecNancy Pryer · San Francisco, CAExecJosh Seidenfeld · San Francisco, CAExecMichelle Arkin · San Francisco, CADirectorScott Clarke · San Francisco, CAExec · DirectorChristian Ottmann · San Francisco, CAExecPeter Dudek · San Francisco, CADirectorMargarita Chavez · San Francisco, CADirectorAndrew E. Spring · New York, NYDirectorAndreas P. Emmanuel · Dallas, TXExec · DirectorYaniv Tepper · Los Angeles, CADirectorAjay Gupta · CHRISTCHURCH, Q2DirectorDonald R. Young · Northborough, MADirectorMichael R. Wittmeyer · Dallas, TXExecJ. E. Virtue · New York, NYDirectorJ. D. Plants · San Francisco, CAExecSteven R. Mitchell · Northborough, MADirectorLawrence J. Konis · Santa Monica, CAExecKendall J. Saville · Dallas, TXExecMamoon Hamid · San Francisco, CADirectorJoshua Merrill · San Francisco, CAExecCraig Kautsch · Fort Worth, TXDirectorRichard Wahlstedt · Chicago, ILDirectorJoseph King · Chicago, ILDirectorMark D. Allsteadt · NORWALK, CTDirectorDavid Festi · Washington, PADirectorEdward Engler · Pittsburgh, PAExecKenneth Martin · Pittsburgh, PAExecRobert Kornblum · Pittsburgh, PAExecHarpoon Ventures Iv GP, LLC · CORONADO, CAExec · Director Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗